14th Danish Conference on Biotechnology and Biomedicine

Therapeutic Proteins

Date Tuesday, May 28 - Wednesday, May 29, 2019
Location Hotel Munkebjerg, Vejle, Denmark
Organizers Danish Biotechnological Society and IDA Biotechnology

The field of therapeutic proteins has been expanding for several years and is more relevant than ever. The huge clinical success of many of these proteins and the large potential of the treatments being developed, requires scientists of diverse backgrounds with many different competences to solve some of the most pressing questions. The potential is reflected in a therapeutic protein market that accounts for more than $100 billion and is estimated to triple in the next 10 years.

The 14th Danish Conference on Biotechnology and Biomedicine will focus on some of the most interesting topics within Therapeutic Proteins and highlight some of the cutting edge research.

The conference will include sessions on:

  • Immuno-oncology
  • Therapeutic antibodies
  • Peptides and Hormones
  • Cell Line Engineering and Protein Production Systems
  • Protein Engineering and Computational Protein Design
  • Post-Translational and Chemical Modifications of Therapeutic Proteins

As well as a session on innovation and entrepreneurship.

There will be poster sessions where students and young researchers can display their research and winners of a poster competition will be able to present their research on the main stage.

List of confirmed speakers:

  • Jan van de Winkel, CEO of Genmab
  • Mathias Uhlén, Professor at the Royal Institute of Technology (KTH) Stockholm
  • Christoph Herwig, Professor at the Technical University of Vienna
  • Dario Neri, Professor at ETH Zurich
  • Jens Nielsen, Head of the BioInnovation Institute
  • Andreas Laustsen, Associate Professor at the Technical University of Denmark
  • Claus Kristensen, CEO of GlycoDisplay
  • Søren Madsen, Head of Department, Bacterial Expression at Bioneer
  • Ana Rute Neves, Senior Department Manager at Chr. Hansen
  • Søren Østergaard, Principle Scientist at Novo Nordisk
  • Pernille Winding Gojkovic, CEO of HØIBERG

The conference is organized by the Danish Biotechnological Society and IDA Biotechnology.